Overview

One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
One month degarelix/comparator treatment for prostate cancer in Chinese population
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Goserelin